Skip to main content
Top
Published in: Clinical Journal of Gastroenterology 4/2019

01-08-2019 | Leflunomide | Case Report

Leflunomide-induced colitis in association with enterocutaneous fistula in an immunosuppressed patient with renal transplant and rheumatoid arthritis

Authors: Allan Mun Fai Kwok, Tia Morosin

Published in: Clinical Journal of Gastroenterology | Issue 4/2019

Login to get access

Abstract

We describe the case of a 68-year-old man who has a complex medical background that included renal transplantation, rheumatoid arthritis and atrial fibrillation. Because of this, he was taking a number of immunosuppressant medications including leflunomide, prednisone and tacrolimus. He had experienced chronic diarrhoea over 18 months which had acutely worsened over the 6 weeks prior to hospital presentation. Recent colonoscopies had been performed to investigate this diarrhoea with biopsies revealing acute and chronic inflammatory changes in the terminal ileum and colon. No infectious cause could be found, with all bacterial and viral stool cultures returning negative. An enterocutaneous fistula had also spontaneously developed through his renal transplant scar in the days preceding hospital admission which complicated the clinical picture. Following dose reduction of leflunomide, there was a significant improvement in the frequency and severity of the patient’s diarrhoea. He continues to be managed non-operatively for his fistula as he is at high risk of peri-operative morbidity and mortality.
Literature
2.
go back to reference Gunendo Z, Benli E, Gogus F, et al. Long term use of leflunomide as a cause of severe diarrhoea? Turk J Rheumatol. 2010;25:41–3.CrossRef Gunendo Z, Benli E, Gogus F, et al. Long term use of leflunomide as a cause of severe diarrhoea? Turk J Rheumatol. 2010;25:41–3.CrossRef
3.
go back to reference Verschueren P, Vandooren AK, Westhovens P. Debilitating diarrhoea and weight loss due to colitis in two RA patients treated with leflunomide. Clin Rheumatol. 2005;24:87–90.CrossRefPubMed Verschueren P, Vandooren AK, Westhovens P. Debilitating diarrhoea and weight loss due to colitis in two RA patients treated with leflunomide. Clin Rheumatol. 2005;24:87–90.CrossRefPubMed
4.
go back to reference Finn S, Bond J, McCarthy D, et al. Angioinvasive aspergillosis presenting as neutropenic colitis. Histopathology. 2006;49:440–1.CrossRefPubMed Finn S, Bond J, McCarthy D, et al. Angioinvasive aspergillosis presenting as neutropenic colitis. Histopathology. 2006;49:440–1.CrossRefPubMed
6.
go back to reference Toquet S, Nguyen Y, Sabbagh A, et al. Severe apoptotic enteropathy caused by methotrexate treatment for rheumatoid arthritis. Jt Bone Spine. 2016;83:217–9.CrossRef Toquet S, Nguyen Y, Sabbagh A, et al. Severe apoptotic enteropathy caused by methotrexate treatment for rheumatoid arthritis. Jt Bone Spine. 2016;83:217–9.CrossRef
7.
go back to reference Lavy A, Militianu D, Eidelman S. Diseases of the intestine mimicking Crohn’s Disease. J Clin Rheumatol. 1992;15(1):17–23. Lavy A, Militianu D, Eidelman S. Diseases of the intestine mimicking Crohn’s Disease. J Clin Rheumatol. 1992;15(1):17–23.
Metadata
Title
Leflunomide-induced colitis in association with enterocutaneous fistula in an immunosuppressed patient with renal transplant and rheumatoid arthritis
Authors
Allan Mun Fai Kwok
Tia Morosin
Publication date
01-08-2019
Publisher
Springer Japan
Published in
Clinical Journal of Gastroenterology / Issue 4/2019
Print ISSN: 1865-7257
Electronic ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-019-00954-2

Other articles of this Issue 4/2019

Clinical Journal of Gastroenterology 4/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.